1 / 31

Anesthetics, NMB, Narcotics, Sedatives & Anticonvulsants

Anesthetics, NMB, Narcotics, Sedatives & Anticonvulsants. Georgia Baptist College of Nursing Kathy Plitnick RN PhD CCRN. Anesthetics. Anesthesia – loss of sensation with/without loss of consciousness Analgesia - loss of pain sensation Types of Anesthesia

Télécharger la présentation

Anesthetics, NMB, Narcotics, Sedatives & Anticonvulsants

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Anesthetics, NMB, Narcotics, Sedatives & Anticonvulsants Georgia Baptist College of Nursing Kathy Plitnick RN PhD CCRN

  2. Anesthetics • Anesthesia – loss of sensation with/without loss of consciousness • Analgesia - loss of pain sensation • Types of Anesthesia • General – controlled state of unconsciousness • Regional – nerve conduction is blocked to a region of the body • Local – blocking of pain impulses on peripheral nerves • Balanced – selection of several different drugs, without excessive CNS depression

  3. Stages of Anesthesia • Stage of Analgesia (I): distortion of sight, hearing, numbness, analgesia • Stage of Delirium (II): loss of consciousness, involuntary activity, psychomotor excitement • Stage of Surgical Anesthesia (III): end of delirium to occurrence of apnea • Stage of Medullary Depression (IV): begins with apnea, ends with circulatory collapse

  4. Parenteral Agents: Propofol (Diprivan) • Hypnotic without analgesia, amnesia • IV rapid induction, short term sedation • Rapid acting, rapid emergence • Adverse: hypotension, bradycardia, apnea • Contraindicated: soybean, egg, L&D • Nursing: • Titrate to sedation level, aseptic technique (fat emulsion), emergency equipment, “wake up” assessment, patent airway, analgesics

  5. Inhalation Anesthetics • Isoflurane (Forane) –volatile liquid • Induction and maintenance – given with Nitrous oxide • Depresses all levels of CNS, skeletal muscle relaxant • Potent respiratory depressant • Minimal depression of myocardium • Potential for malignant hyperthermia • Depresses kidney function

  6. Isoflurane • Post operative shivering • IV Demerol, rewarming • Monitor vs, temperature frequently • Prevent aspiration • Monitor U/O

  7. Nitrous Oxide • Nonflammable, inorganic gas, colorless, odorless • Cortical depression • Good analgesic, weak anesthetic • Rapidly absorbed through lungs • Adverse: depresses cardiac contractility, hypoxia

  8. Local: Lidocaine • Inhibits transport of ions across neuronal membranes • Prevents initiation & conduction of nerve impulses • Routes: topical, infiltration, mucosal, IV • Nursing: assess degree of numbness, ensure gag reflex intact after oral sprays • Infiltration: used with Epinephrine to prolong local effect

  9. Neuromuscular Blockers • Cause muscle relaxation, paralyzation • Short term use: facilitate intubation, procedures in mech ventilated • Long term use: mechanical ventilation, control agitation, decrease tissue oxygen demands, increased ICP • Always administer with an analgesic &/or sedative • Patient is completely dependent • Protect the patient

  10. Depolarizing Agents: Succinylcholine (Anectine) • Depolarization of motor end plates, bind to receptors • Muscle contraction appear as fasciculations (tremors) followed by muscle relaxation • Complete paralysis in 2-3 minutes • No effect on CNS

  11. Succinylcholine • Adverse: stimulates vagal ganglia • Apnea • Histamine release • Increased intraocular pressure • Malignant hyperthermia • Never assume a paralyzed patient is asleep • Mechanical ventilation support

  12. Nondepolarizing Agents • Block action of acetylcholine • Prevents depolarization of muscle membrane, muscle contraction cannot occur • Used in OR – to expose operative site, close wound • Anesthesiologist: facilitate intubation

  13. Tubocurarine (Tubarine) • Gradual paralysis over 1-5 minutes without fasciculation • Sequence of paralysis • Persists for 40-60 minutes • Reversed by anticholinesterases • Effects: hypotension, peripheral vasodilatation, myocardial depression, reflex tachycardia, increased secretions, decreased u/o, GI motility

  14. Tubocurarine • Toxic: prolonged apnea, cardiovascular collapse, recurarization • Nursing: • Hypotension profound in hypovolemia • Rehydrate • Avoid use in asthmatics • Excreted by kidneys – slower recovery or repeated doses of anticholinesterases

  15. Narcotics – Morphine • Opioid analgesic, binds to opiate receptors • Alters perception to painful stimuli • Produces CNS depression • Uses: severe pain, pulmonary edema, acute MI • Available: oral, IM, IV, SC, rectal, epidural, intrathecal

  16. Morphine • Adverse: confusion, sedation, respiratory depression, arrest, hypotension, constipation, urinary retention, itching, dependence • Nursing: • Assess VS, type, location & intensity of pain • Assess bowel function • Co-administration of nonopioid analgesics • Discontinue gradually • Give IVP slowly, safety precautions

  17. Codeine • Mild narcotic agonist • Decreases cough reflex, GI motility • Completely absorbed from IM sites • Use Cautiously in head trauma, increased ICP, undiagnosed abdominal pain • Often combined with analgesic (ASA, tylenol) Tylenol #2 – 15 mg Codeine

  18. Pentazocine (Talwin) • Narcotic Agonist-Antagonist • Antagonist properties may result in opioid withdrawal • Withdrawal symptoms: vomiting, restlessness, abdominal cramps, increased BP & temperature • Additional adverse: hallucinations, euphoria, lightheadedness • IM injections deep into well-developed muscle

  19. Narcotic Antagonist – Naloxone (Narcan) • Antidote for opioid overdose • Reverses CNS depression • Results in sympathetic stimulation • IVP: 0.02 – 0.2 mg q 3-5 minutes • Always assess pain after IV Narcan • Resuscitation equipment readily available

  20. CNS Depressants • Benzodiazepines: Lorazepam (Ativan) • Potentiates GABA – inhibitory NT • Sedation, amnesia • Uses: anxiety, seizures, insomnia, diagnostic procedures

  21. Sleep Stages • NREM: • 1: Relaxed wakefulness • 2: Light sleep – 50% of sleep • 3 & 4: Slow wave (delta), deep restorative, secrete hormones, enhance immune function, 15-50% • REM: • Mentally, emotionally restorative • Psychological problems from deprivation • 90 minute cycles

  22. CNS Depressants & REM sleep • Barbiturates • Suppress REM sleep • Rebound effect • Benzodiazepines • Do not suppress REM sleep

  23. Lorazepam (Ativan) • Available oral, IM, IV (1-5 min) • Half-life 10-20 hours • Nursing: • Assess degree of anxiety • Psychological, physical dependence • Bedrest, safety precautions (IV) • Slow IVP • Avoid ETOH • Seizure management • Renal function

  24. Anticonvulsant Therapy • Seizures: abnormal electrical activity in nerve cells, discharges occur in cerebral cortex • Localized areas or entire brain • Idiopathic: no specific cause • Nonidiopathic: abscess, trauma, encephalitis, CVA, uremia, ETOH, drug overdoses, sudden withdrawal, hypoglycemia, hypocalcemia, fever

  25. Anticonvulsants • Block movement of sodium ions , less excitable membranes • Enhance GABA activity • Long term therapy • Oral use, IV • Stop a seizure: Lorazepam, Diazepam • Prevent seizure: phenobarbital, dilantin

  26. Phenytoin (Dilantin) • Treatment/prevention tonic-clonic seizures • Alters ion transport • Absorb slowly, 18-24 hours • Steady state 1-3 weeks • Adverse: ataxia, drowsiness, hypotension, gingival hyperplasia, slurred speech

  27. Phenytoin • Nursing: • Characteristics of seizure • Oral hygiene • Hypersensitivity reaction • Seizure precautions • IVP precautions • Patient identification • Urine: pink, red, reddish brown • Avoid antacids • Therapeutic levels: 10-20 mcg/ml

  28. Phenobarbital • Produces CNS depression • Decreases motor activity, alters cerebellar function • Anticonvulsant activity, sedation • Uses: tonic-clonic, febrile seizures • Half-life 2-6 days • Adverse: hangover, delirium, drowsiness, excitation, hypotension

  29. Phenobarbital • Frequent VS with IV use • Resuscitation equipment • Dependence • Suicide precautions • Seizure assessment, precautions • Evaluate hepatic, renal, CBC • Therapeutic level: 10-40 mcg/ml • Slow IVP

  30. Anticonvulsants • Clonazepam (Klonopin): petit mal, myoclonic, long term treatment • Ethosuximide (Zarontin): absence seizures, peak levels in 3-7 hours, anorexia & gastric upset a problem • Carbamazepine (Tegretol): tonic-clonic, partial seizures, related to TCA’s, watch LFT’s, BUN, bilirubin, plt ct.

More Related